New study tracks Belimumab's Long-Term kidney benefits in lupus patients

NCT ID NCT06527872

Recruiting now Knowledge-focused Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study follows 300 adults with lupus nephritis who are already taking belimumab as part of their routine care. Researchers will track kidney function for up to 5 years to see how well the drug preserves renal health and prevents the need for dialysis or transplant. The goal is to understand belimumab's real-world effectiveness beyond clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: belimumab
What this could lead to: If successful, this study could confirm that belimumab helps preserve kidney function in lupus nephritis patients over the long term.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only observes current use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lupus nephritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUPUS NEPHRITIS

Contacts and locations

Locations

GSK Investigational Site
RECRUITING

Hixson, Tennessee, 37343-7908, United States
GSK Investigational Site
RECRUITING

Marseille, 13005, France
GSK Investigational Site
RECRUITING

Rozzano, Milan, 20089, Italy
GSK Investigational Site
RECRUITING

Fukuoka, 807-8556, Japan
GSK Investigational Site
RECRUITING

Baltimore, Maryland, 21287, United States
GSK Investigational Site
RECRUITING

Charlotte, North Carolina, 28207, United States
GSK Investigational Site
RECRUITING

Columbus, Ohio, 43201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.